History’s deadliest infectious disease has a new adversary. Although many think of tuberculosis as a disease of the past, it still kills 1.2 million people annually. Last month, scientists at Texas A&M AgriLife Research published a study in Nature, revealing that they had developed a new compound that could be a tuberculosis treatment breakthrough. The…
GSK to invest £1 billion on infectious disease research
GSK plc (NYSE:GSK) has announced its plans to spend £1 billion over the next ten years on R&D focused on infectious diseases that disproportionately affect lower-income countries. Diseases covered in the research will include malaria, tuberculosis, HIV, neglected tropical diseases (NTDs) and antimicrobial resistance (AMR). The HIV focus will be through ViiV Healthcare, a joint…